Thomas Dehmel

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Journal: Annals of clinical and translational neurology
Published: August 11, 2017

Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes.

Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes.

Journal: Infection and immunity
Published: July 12, 2015

Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.

Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.

Journal: Journal of neurology
Published: November 14, 2014

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.

Journal: Neurology
Published: November 02, 2014

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 15, 2014

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.

Journal: Annals of clinical and translational neurology
Published: June 09, 2014

Fingolimod treatment promotes regulatory phenotype and function of B cells.

Fingolimod treatment promotes regulatory phenotype and function of B cells.

Journal: Annals of clinical and translational neurology
Published: June 03, 2014

Interleukin-17 impedes Schwann cell-mediated myelination.

Interleukin-17 impedes Schwann cell-mediated myelination.

Journal: Journal of neuroinflammation
Published: January 19, 2014

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Journal: Annals of neurology
Published: December 28, 2013

Monomethylfumarate reduces in vitro migration of mononuclear cells.

Monomethylfumarate reduces in vitro migration of mononuclear cells.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: October 21, 2013

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.

Journal: Neurology
Published: September 20, 2013

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.

Journal: JAMA neurology
Published: April 20, 2013
Showing 1-12 of 21

Last Updated: 09/26/2026